Seaport Therapeutics SPTX
NASDAQ SPTX
$19.12 -0.86 (-4.30%)
At close: Nov 16, 2026 · 4:00 PM EST

Seaport Therapeutics (SPTX) Other Accumulated Expenses (2024 - 2026)

Updated

Seaport Therapeutics (SPTX) reported Other Accumulated Expenses of $680,000 for Q3 2026, down 61.2% from the prior quarter.

Analysis

Seaport Therapeutics (SPTX) Other Accumulated Expenses (2024 - 2026) Analysis & Trends

At the end of FY2025, Seaport Therapeutics posted Other Accumulated Expenses of $512,000, up 45.9% from FY2024.

  • By year, Other Accumulated Expenses came in at $351,000 in FY2024.
  • Five-year quarterly Other Accumulated Expenses spans a low of $351,000 in Q4 2024 and a high of $2.01 million in Q1 2026.
  • Per Business Quant data, the three quarters before Q3 2026 came in at $1.75 million (Q2 2026), $2.01 million (Q1 2026) and $512,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Seaport Therapeutics 1.03 Bn 63.31 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 680,000.00
Jun 30, 2026 1.75 Mn
Mar 31, 2026 2.01 Mn
Dec 31, 2025 512,000.00
Dec 31, 2024 351,000.00
API Access

Seaport Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=SPTX&period=max&api_key=YOUR_API_KEY